PaxMedica, Inc. (PXMD)
OTCMKTS: PXMD · Delayed Price · USD
0.244
+0.030 (14.02%)
Jul 19, 2024, 4:00 PM EDT - Market open
PaxMedica Employees
As of December 31, 2023, PaxMedica had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,592,738
Market Cap
1.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | 2 | 40.00% |
Dec 31, 2022 | 5 | 1 | 25.00% |
Dec 31, 2021 | 4 | -2 | -33.33% |
Dec 31, 2020 | 6 | 2 | 50.00% |
Dec 31, 2019 | 4 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
PXMD News
- 2 months ago - PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - GlobeNewsWire
- 3 months ago - PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - GlobeNewsWire
- 3 months ago - PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - GlobeNewsWire
- 3 months ago - Why is PaxMedica (PXMD) stock surging today? - Invezz
- 3 months ago - PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - GlobeNewsWire
- 4 months ago - PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments - GlobeNewsWire
- 8 months ago - PaxMedica Releases Fireside Chat Video with CEO Howard Weisman - Accesswire
- 8 months ago - PaxMedica Announces Closing of $7.0 Million Public Offering - Accesswire